Pfizer booster improved to fight omicron, as hospitalizations rise to 3-month high
June 27, 2022 at 11:52 AM EDT
Pfizer Inc. and partner BioNTech SE said the update to their COVID-19 booster shot showed a "high immune response" against the omicron variant, in time for an FDA meeting and as the daily average of COVID-19-related hospitalizations rose to a 3-month high.
